Korean J Lab Med.  2007 Feb;27(1):56-61. 10.3343/kjlm.2007.27.1.56.

Incidence and Clinical Significance of Sex Chromosome Losses in Bone Marrow of Patients with Hematologic Diseases

• Huh J
• Moon H
• Chung WS

• KMID: 1121661
• DOI: http://doi.org/10.3343/kjlm.2007.27.1.56

Abstract

BACKGROUND: Loss of sex chromosomes in bone marrow is observed both in elderly persons as an aging phenomenon and in patients with hematologic malignancies. The purpose of this study was to evaluate the incidence and clinical significance of sex chromosome losses in patients with hematologic diseases, comparing the characteristics between patients with sole and secondary sex chromosome losses in conjunction with other chromosomal abnormalities. METHODS: Study group included 868 patients with hematologic diseases between June 1998 and May 2006. The cells of bone marrow aspirates were processed using unstimulated culture methods such as direct, 24-hr and/or 48-hr culture. Sex chromosome losses were included in the karyotype, when X or Y chromosome loss is observed in more than 2 metaphase cells. RESULTS: The sex chromosome losses in bone marrow were found in 5.1% of the patients and 1.8% showed sex chromosome losses as a sole chromosomal abnormality. According to the disease categories, the incidences of sex chromosome losses were as follows: acute myelogenous leukemia (AML), 9.5%; acute lymphoblastic leukemia, 0%; myelodysplastic syndrome, 6.0%; chronic myelogenous leukemia 3.6%; myeloproliferative disorders, 1.3%; multiple myeloma (MM), 13.0%; chronic lymphocytic leukemia, 0%; malignant lymphoma, 3.8%; and benign hematologic diseases 2.2%. The patients with sex chromosome losses as a sole chromosomal abnormality were all male and median age was higher than that of patients with sex chromosome losses as a secondary abnormality (64 vs. 58 yr, P=0.02). The proportion of metaphase cells with sex chromosome losses was significantly lower in patients with sex chromosome losses as a sole chromosomal abnormality (40% vs. 100%, P<0.0001). The changes of sex chromosome loss were correlated with the disease status of AML and MM. CONCLUSIONS: These results suggest that secondary sex chromosome losses in conjunction with other chromosomal abnormalities seem to be one of the clonal abnormalities, whereas sex chromosome losses as a sole change seem to be an aging phenomenon, but further studies are needed.

Keyword

Sex chromosome; Bone marrow; Aging; Clonal

MeSH Terms

Adult
Aged
Bone Marrow Cells/*cytology
*Chromosomes, Human, X
*Chromosomes, Human, Y
Female
Hematologic Diseases/*diagnosis/*genetics
Humans
Male
Middle Aged
*Sex Chromosome Aberrations

Reference

References

1. Stone JF, Sandberg AA. Sex chromosome aneuploidy and aging. Mutat Res. 1995; 338:107–13.

2. Nath J, Tucker JD, Hando JC. Y chromosome aneuploidy, micronuclei, kinetochores and aging in men. Chromosoma. 1995; 103:725–31.

3. Galloway SM, Buckton KE. Aneuploidy and ageing: chromosome studies on a random sample of the population using G-banding. Cytogenet Cell Genet. 1978; 20:78–95.

4. Jarvik LF, Yen FS, Fu TK, Matsuyama SS. Chromosomes in old age: a six year longitudinal study. Hum Genet. 1976; 33:17–22.

5. Guttenbach M, Koschorz B, Bernthaler U, Grimm T, Schmid M. Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. Am J Hum Genet. 1995; 57:1143–50.

6. United Kingdom Cancer Cytogenetics Group (UKCCG). Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosomes Cancer. 1992; 5:83–8.

7. Herens C, Brasseur E, Jamar M, Vierset L, Schoenen I, Koulischer L. Loss of the Y chromosome in bone marrow cells: results on 1907 consecutive cases of leukaemia and preleukaemia. Clin Lab Haematol. 1999; 21:17–20.

8. Wiktor A, Rybicki BA, Piao ZS, Shurafa M, Barthel B, Maeda K, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer. 2000; 27:11–6.

9. Smith A, Watson N, Sharma P. Frequency of trisomy 15 and loss of the Y chromosome in adult leukemia. Cancer Genet Cytogenet. 1999; 114:108–11.

10. Abeliovich D, Yehuda O, Ben-Neriah S, Or R. Loss of Y chromosome. An age-related event or a cytogenetic marker of a malignant clone? Cancer Genet Cytogenet. 1994; 76:70–1.

11. Shaffer LG, Tommerup N, editors. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger;2005.

12. Holmes RI, Keating MJ, Cork A, Trujillo JM, McCredie KB, Freireich EJ. Loss of the Y chromosome in acute myelogenous leukemia: a report of 13 patients. Cancer Genet Cytogenet. 1985; 17:269–78.